Increasing evidence has demonstrated that the disruption of Smad7 expression participates in a number of diseases, including inflammatory bowel disease [24], hepatic fibrosis [45], cardiac remodeling [46], cancer [47] and kidney disease [48]. Here, SMAD7 is linked to cancer.